RhumbLine Advisers’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.76M | Sell |
187,732
-4,561
| -2% | -$104K | ﹤0.01% | 1498 |
|
|
2026
Q1 | $4.11M | Buy |
192,293
+6,241
| +3% | +$130K | ﹤0.01% | 1499 |
|
|
2025
Q4 | $3.98M | Sell |
186,052
-30,264
| -14% | -$620K | ﹤0.01% | 1522 |
|
|
2025
Q3 | $3.62M | Sell |
216,316
-3,517
| -2% | -$52.7K | ﹤0.01% | 1591 |
|
|
2025
Q2 | $3.15M | Buy |
219,833
+2,887
| +1% | +$39.6K | ﹤0.01% | 1642 |
|
|
2025
Q1 | $3.14M | Sell |
216,946
-7,755
| -3% | -$110K | ﹤0.01% | 1596 |
|
|
2024
Q4 | $2.95M | Buy |
224,701
+3,822
| +2% | +$52.8K | ﹤0.01% | 1690 |
|
|
2024
Q3 | $2.56M | Sell |
220,879
-5,064
| -2% | -$47.7K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $1.71M | Buy |
225,943
+42
| +0% | +$347 | ﹤0.01% | 1967 |
|
|
2024
Q1 | $2.27M | Buy |
225,901
+569
| +0.3% | +$5.29K | ﹤0.01% | 1848 |
|
|
2023
Q4 | $2.1M | Sell |
225,332
-2,549
| -1% | -$26.4K | ﹤0.01% | 1876 |
|
|
2023
Q3 | $2.9M | Sell |
227,881
-43,524
| -16% | -$597K | ﹤0.01% | 1662 |
|
|
2023
Q2 | $3.86M | Sell |
271,405
-12,617
| -4% | -$177K | ﹤0.01% | 1535 |
|
|
2023
Q1 | $4.24M | Buy |
284,022
+10,854
| +4% | +$164K | 0.01% | 1420 |
|
|
2022
Q4 | $4.06M | Sell |
273,168
-2,479
| -0.9% | -$40.5K | 0.01% | 1397 |
|
|
2022
Q3 | $4.55M | Buy |
275,647
+53,810
| +24% | +$1.08M | 0.01% | 1291 |
|
|
2022
Q2 | $4.66M | Buy |
221,837
+25,676
| +13% | +$524K | 0.01% | 1281 |
|
|
2022
Q1 | $4.61M | Buy |
196,161
+8,179
| +4% | +$200K | 0.01% | 1366 |
|
|
2021
Q4 | $5.12M | Buy |
187,982
+5,493
| +3% | +$147K | 0.01% | 1343 |
|
|
2021
Q3 | $5.19M | Sell |
182,489
-32,678
| -15% | -$996K | 0.01% | 1343 |
|
|
2021
Q2 | $6.49M | Sell |
215,167
-22,516
| -9% | -$664K | 0.01% | 1285 |
|
|
2021
Q1 | $6.05M | Sell |
237,683
-3,099
| -1% | -$79.4K | 0.01% | 1302 |
|
|
2020
Q4 | $5.91M | Sell |
240,782
-30,674
| -11% | -$576K | 0.01% | 1259 |
|
|
2020
Q3 | $4.42M | Sell |
271,456
-31,605
| -10% | -$588K | 0.01% | 1242 |
|
|
2020
Q2 | $5.18M | Buy |
303,061
+68,690
| +29% | +$1.02M | 0.01% | 1195 |
|
|
2020
Q1 | $2.73M | Buy |
234,371
+18,050
| +8% | +$372K | 0.01% | 1379 |
|
|
2019
Q4 | $6.01M | Buy |
216,321
+3,045
| +1% | +$76.4K | 0.01% | 1147 |
|
|
2019
Q3 | $4.82M | Sell |
213,276
-5,759
| -3% | -$131K | 0.01% | 1206 |
|
|
2019
Q2 | $5.53M | Sell |
219,035
-7,228
| -3% | -$194K | 0.01% | 1136 |
|
|
2019
Q1 | $6.15M | Sell |
226,263
-13,260
| -6% | -$445K | 0.01% | 1061 |
|
|
2018
Q4 | $7.9M | Buy |
239,523
+67,867
| +40% | +$2.73M | 0.02% | 830 |
|
|
2018
Q3 | $8.01M | Sell |
171,656
-2,817
| -2% | -$129K | 0.02% | 801 |
|
|
2018
Q2 | $7.55M | Sell |
174,473
-10,216
| -6% | -$490K | 0.02% | 826 |
|
|
2018
Q1 | $10.3M | Sell |
184,689
-7,140
| -4% | -$391K | 0.02% | 654 |
|
|
2017
Q4 | $10.3M | Sell |
191,829
-15,730
| -8% | -$742K | 0.02% | 675 |
|
|
2017
Q3 | $8.95M | Buy |
207,559
+17,987
| +9% | +$855K | 0.02% | 726 |
|
|
2017
Q2 | $11.4M | Sell |
189,572
-17,810
| -9% | -$1.06M | 0.03% | 581 |
|
|
2017
Q1 | $14.4M | Buy |
207,382
+14,353
| +7% | +$997K | 0.03% | 516 |
|
|
2016
Q4 | $12.9M | Buy |
193,029
+9,426
| +5% | +$613K | 0.03% | 530 |
|
|
2016
Q3 | $12.2M | Buy |
183,603
+5,805
| +3% | +$397K | 0.03% | 498 |
|
|
2016
Q2 | $12.9M | Buy |
177,798
+4,708
| +3% | +$324K | 0.04% | 454 |
|
|
2016
Q1 | $11.2M | Sell |
173,090
-140
| -0.1% | -$9.29K | 0.03% | 492 |
|
|
2015
Q4 | $12.4M | Buy |
173,230
+3,849
| +2% | +$285K | 0.04% | 430 |
|
|
2015
Q3 | $13M | Buy |
169,381
+5,149
| +3% | +$415K | 0.04% | 416 |
|
|
2015
Q2 | $12.2M | Buy |
164,232
+19,414
| +13% | +$1.4M | 0.04% | 452 |
|
|
2015
Q1 | $10.5M | Buy |
144,818
+12,800
| +10% | +$890K | 0.03% | 509 |
|
|
2014
Q4 | $8.73M | Buy |
132,018
+2,560
| +2% | +$156K | 0.03% | 547 |
|
|
2014
Q3 | $7.1M | Sell |
129,458
-1,843
| -1% | -$105K | 0.02% | 598 |
|
|
2014
Q2 | $7.63M | Sell |
131,301
-15,178
| -10% | -$893K | 0.02% | 591 |
|
|
2014
Q1 | $9.08M | Sell |
146,479
-2,719
| -2% | -$158K | 0.03% | 534 |
|
|
2013
Q4 | $7.96M | Sell |
149,198
-14,472
| -9% | -$777K | 0.02% | 590 |
|
|
2013
Q3 | $8.22M | Buy |
163,670
+1,194
| +0.7% | +$58.3K | 0.03% | 573 |
|
|
2013
Q2 | $7.44M | Buy |
+162,476
| New | +$7.27M | 0.02% | 590 |
|
Other funds holding MD
WA
RhumbLine Advisers's MD Position: Q2 2026 in Review
RhumbLine Advisers reduced its Pediatrix Medical (MD) stake by 2.4% in Q2 2026, selling an estimated $104K and leaving 187,732 shares worth $4.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1498.
RhumbLine Advisers first reported a position in MD in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.4M in Q1 2017. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.
- RhumbLine Advisers held 187,732 shares of Pediatrix Medical worth $4.76M as of Q2 2026.
- RhumbLine Advisers sold 4,561 Pediatrix Medical shares in Q2 2026, an estimated $104K.
- Pediatrix Medical made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1498 holding.
- RhumbLine Advisers first reported a position in Pediatrix Medical in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Pediatrix Medical position peaked at $14.4M in Q1 2017.
- 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.